Gene · 873
Papers2,488
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,488
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolutionary Study of Disorder in Protein Sequences. | Biomolecules | 2020 | 33036302 | PubTator, text mining | PubMed |
| ADAM17 cytoplasmic domain modulates Thioredoxin-1 conformation and activity. | Redox Biol | 2020 | 33011677 | PubTator, text mining | PubMed |
| Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. | Lancet | 2020 | 33002431 | PubTator, text mining | PubMed |
| An application of activity theory to the "problem of e-books". | Heliyon | 2020 | 32995643 | PubTator, text mining | PubMed |
| Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | Cell Death Dis | 2020 | 32994395 | PubTator, text mining | PubMed |
| Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction. | Int J Mol Sci | 2020 | 32993084 | PubTator, text mining | PubMed |
| Molecular and Mechanical Mechanisms Regulating Ductus Arteriosus Closure in Preterm Infants. | Front Pediatr | 2020 | 32984222 | PubTator, text mining | PubMed |
| The Role of Eicosanoids in Gynecological Malignancies. | Front Pharmacol | 2020 | 32982722 | PubTator, text mining | PubMed |
| Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin. | Drug Des Devel Ther | 2020 | 32921983 | PubTator, text mining | PubMed |
| Phylogenetic analysis of plant multi-domain SEC14-like phosphatidylinositol transfer proteins and structure-function properties of PATELLIN2. | Plant Mol Biol | 2020 | 32915352 | PubTator, text mining | PubMed |
| Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease. | Drug Metab Rev | 2020 | 32898444 | PubTator, text mining | PubMed |
| Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy. | Lancet Oncol | 2020 | 32888472 | PubTator, text mining | PubMed |
| Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation. | Diagnostics (Basel) | 2020 | 32878211 | PubTator, text mining | PubMed |
| Involvement of angiotensin II receptor type 1/NF-κB signaling in the development of endometriosis. | Exp Ther Med | 2020 | 32855697 | PubTator, text mining | PubMed |
| Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology. | Front Pharmacol | 2020 | 32848787 | PubTator, text mining | PubMed |
| D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome. | Int J Mol Sci | 2020 | 32842637 | PubTator, text mining | PubMed |
| The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia. | Antioxidants (Basel) | 2020 | 32839417 | PubTator, text mining | PubMed |
| Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition. | Oncogenesis | 2020 | 32814764 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - Involvement of carbonyl reductase 1. | Eur J Pharm Sci | 2020 | 32801001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/873/papers?page=39